GRAN

COM:GRANNUSTHERAPEUTICS

Grannus Therapeutics

  • Privately Held

Grannus Therapeutics is focused on developing Hsp90β-selective inhibitors for cancer treatment, addressing limitations of previous inhibitors.

peer of